Abingworth LLP Portfolio Holdings

Abingworth LLP

  • $301 Million
  • Q4 2022

Abingworth LLP has filed its 13F form on February 10, 2023 for Q4 2022 where it was disclosed a total value porftolio of $301 Million distributed in 19 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Vaxcyte, Inc. with a value of $96.8M, Verona Pharma PLC with a value of $64.2M, Vera Therapeutics, Inc. with a value of $57.3M, Hille Vax, Inc. with a value of $30.8M, and Adicet Bio, Inc. with a value of $18.9M.

Examining the 13F form we can see an increase of $8.99M in the current position value, from $292M to 301M.

Abingworth LLP is based out at London, X0

Below you can find more details about Abingworth LLP portfolio as well as his latest detailed transactions.

Portfolio value $301 Million
Healthcare: $301 Million

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$60.2M
$30.8 Million 10.2% of portfolio
1,838,486
Q2 2022 New
$66.3M
$2.2 Million 0.73% of portfolio
3,333,333
Q3 2020 New
$55.5M
$323,000 0.11% of portfolio
281,636
Q3 2022 New

Summary

  • Portfolio
  • No. of Stocks 19
  • Current Value $301 Million
  • Prior Value $292 Million
  • Filing
  • Period Q4 2022
  • Filing Date February 10, 2023
  • Form Type 13F-HR
  • Activity in Q4 2022
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Abingworth LLP Portfolio

Follow Abingworth LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abingworth LLP, based on Form 13F filings with the SEC.

News

Stay updated on Abingworth LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email